CRISPR

CRISPR1-ahr2

ID
ZDB-CRISPR-180726-34
Name
CRISPR1-ahr2
Previous Names
None
Target
Sequence
5' - GTACATATGCGGTCAAGAAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
osu1 ahr2
Expression
Gene expression in Wild Types + CRISPR1-ahr2
No data available
Phenotype
Phenotype resulting from CRISPR1-ahr2
No data available
Phenotype of all Fish created by or utilizing CRISPR1-ahr2
Phenotype Fish Conditions Figures
whole organism wfikkn1 expression amount, ameliorated ahr2osu1/osu1 chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 2 from Shankar et al., 2022
whole organism decreased fertility, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 4 with image from Garcia et al., 2018
frontal bone morphology, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 5 with image from Garcia et al., 2018
supraorbital bone morphology, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 5 with image from Garcia et al., 2018
caudal fin morphology, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 5 with image from Garcia et al., 2018
ovarian follicle stage IV decreased amount, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 4 with image from Garcia et al., 2018
ovarian follicle stage III increased amount, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 4 with image from Garcia et al., 2018
whole organism ahrrb expression increased amount, abnormal ahr2osu1/osu1 (SPF 5-D) chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 3 from Garcia et al., 2018
opercular flap morphology, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 5 with image from Garcia et al., 2018
visual behavior process quality, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 6 from Garcia et al., 2018
ovarian follicle stage IV degenerate, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 4 with image from Garcia et al., 2018
whole organism cyp1b1 expression increased amount, abnormal ahr2osu1/osu1 (SPF 5-D) chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 3 from Garcia et al., 2018
whole organism cyp1c1 expression increased amount, abnormal ahr2osu1/osu1 (SPF 5-D) chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 3 from Garcia et al., 2018
anal fin morphology, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 5 with image from Garcia et al., 2018
mandibular arch skeleton malformed, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 5 with image from Garcia et al., 2018
dorsal fin morphology, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 5 with image from Garcia et al., 2018
whole organism ahrra expression increased amount, abnormal ahr2osu1/osu1 (SPF 5-D) chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 3 from Garcia et al., 2018
whole organism cyp1a expression increased amount, abnormal ahr2osu1/osu1 (SPF 5-D) chemical treatment by environment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 3 from Garcia et al., 2018
female organism decreased fecundity, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 4 with image from Garcia et al., 2018
startle response process quality, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 6 from Garcia et al., 2018
dentary morphology, abnormal ahr2osu1/osu1 (SPF 5-D) standard conditions Fig. 5 with image from Garcia et al., 2018
Citations